Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
Rebranded Galapagos finally finds buyer for cell therapies
Lakefront Biotherapeutics—the new name for Belgium’s Galapagos Therapeutics—has found a buyer for its unwanted cell therapy pipeline.
James Waldron
Oct 15, 2026 4:09am
Caribou’s ‘heartbreaking’ call to lay off staff, halt pipeline
Oct 7, 2026 5:00am
Adicet Bio CAR-T sparks lupus remissions in early-stage trial
Sep 28, 2026 6:45am
Kyverna pubs 1-year miv-cel data as CAR-T peers hit safety snags
Sep 24, 2026 6:02am
Cellectis cans allogeneic CAR-Ts to hop aboard in vivo bandwagon
Sep 14, 2026 5:26am
BMS’ pivotal CAR-T multiple myeloma trial hits primary endpoint
Sep 8, 2026 9:11am
